Venture capitalists start to warm to brain diseases
Longtime venture capital star Beth Seidenberg and former Amgen R&D chief Sean Harper say they have funded 10 companies from their new fund, Westlake Village BioPpartners. But only three — the cell therapy companies Kyverna Therapeutics, Tmunity, and Arsenal Biosciences — are publicly known. Any hints?
Neuroscience.
“My pattern matching over the years is when a pharma company says I'm out of a particular area, that's a perfect time for venture capitalists to jump in because it means that they're hard problems,” said Seidenberg. Those are perfect for the focus startups bring, she said.
Principally, they meant neurodegenerative diseases, like Alzheimer’s. But they also expressed some interest in chronic pain, where Harper thinks animal models may work. Psychiatry? It’s so hard, Harper said, but he didn’t want to rule out trying in the future.
Read more.
Neuroscience.
“My pattern matching over the years is when a pharma company says I'm out of a particular area, that's a perfect time for venture capitalists to jump in because it means that they're hard problems,” said Seidenberg. Those are perfect for the focus startups bring, she said.
Principally, they meant neurodegenerative diseases, like Alzheimer’s. But they also expressed some interest in chronic pain, where Harper thinks animal models may work. Psychiatry? It’s so hard, Harper said, but he didn’t want to rule out trying in the future.
Read more.
.png)
No hay comentarios:
Publicar un comentario